Atomera Inc (ATOM) · Oct 29, 2026 · Earnings
Miss — EPS $(0.15) vs $(0.12) consensus; revenue $0 vs ~$100K
Atomera earnings show broader GAA, memory and GaN engagement, but the early-stage licensing model still produced no Q3 revenue and missed EPS expectations.
Atomera is still an early-stage semiconductor materials company trying to turn its MST transistor technology into licensing revenue across AI-focused GAA logic, DRAM/HBM/NAND memory and GaN-on-silicon; the current story is expanding customer validation, not commercial-scale sales. Its recent IQE GaN collaboration and broader GAA push fit that strategy.
The business-development narrative improved, but remains pre-commercial. Atomera says it is now engaged with three of four GAA customers, while also highlighting a simpler MST approach for next-generation DRAM and the IQE joint-development effort. 〔0〕 〔1〕 Those are meaningful validation milestones for the technology, but the IQE agreement was already announced on October 22, 2026, so much of the strategic upside was known before this filing.
The quarter missed the modest financial bar because commercialization still has not arrived. Revenue was zero versus a published consensus of roughly $100,000, and the $0.15 per-share loss was worse than the expected $0.12 loss. The absence of revenue is the more important signal: customer engagement and technical progress have not yet converted into recurring licensing or engineering income.
| Q3 2026 | Q3 2025 | Consensus | |
|---|---|---|---|
| Revenue (Financial Review) | — | $11K | $100K |
| Net loss per share (Financial Review) | $(0.15) | $(0.17) | $(0.12) |
| Net loss (Financial Review) | $(6.006)M | $(5.573)M | |
| Adjusted EBITDA (Financial Review) | $(4.572)M | $(4.440)M | |
| Cash, equivalents & ST investments (Balance Sheet Information) | $34.828M | $20.322M |
Cash buys time, not proof of adoption. The filing shows $34.8 million of cash and short-term investments with no debt, giving Atomera room to keep funding development, customer work and licensing efforts. But operating expenses rose to $6.3 million from $5.7 million a year earlier while revenue remained negligible, so the company is still spending ahead of monetization rather than demonstrating a self-funding commercial model.
Bottom line: Atomera’s technology pipeline is getting broader and more credible, but this quarter did not move it closer to revenue in a measurable way. Against a low consensus bar, the zero-revenue quarter and EPS miss make the filing a negative earnings read despite the stronger engagement pipeline.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!